Similar articles

• [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].

  Horsch S, Claeys L. Horsch S, et al. Vasa Suppl. 1992;35:151-2. Vasa Suppl. 1992. PMID: 1481024 Clinical Trial. German. No abstract available.
• [Prostaglandin E1 in intermittent claudication].

  Scheffler P, de la Hamette D, Rogatti W. Scheffler P, et al. Vasa Suppl. 1992;35:147-8. Vasa Suppl. 1992. PMID: 1481022 Clinical Trial. German. No abstract available.
• [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].

  Kozlitskiĭ AP. Kozlitskiĭ AP. Vestn Khir Im I I Grek. 1982 Sep;129(9):120-3. Vestn Khir Im I I Grek. 1982. PMID: 7147583 Russian. No abstract available.
• Prostanoids in therapy of peripheral arterial occlusive disease.

  Creutzig A, Caspary L. Creutzig A, et al. Therapie. 1991 May-Jun;46(3):241-5. Therapie. 1991. PMID: 1792658 Review.
• Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.

  Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. Chopra HK, et al. J Med. 1988;19(2):89-107. J Med. 1988. PMID: 3049876 Review.